Evidence map›Paper›PMID 35463347›Full record

ArticleFrontiers in oncology2022

Corrigendum: PET/Ct Imaging of Activated Cancer-Associated Fibroblasts Predict Response to PD-1 Blockade in Gastric Cancer Patients.

Xiaoxiang Rong, Jinyu Lv, Yantan Liu, Zhaojun Wang, Dongqiang Zeng, Yuedan Li, Shaowei Li, Jianhua Wu, Zheyu Shen, Min Shi and 3 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Xiaoxiang RongDepartment of Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Jinyu LvDepartment of Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Yantan LiuDepartment of Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Zhaojun WangDepartment of Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Dongqiang ZengDepartment of Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Yuedan LiDepartment of Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Shaowei LiDepartment of Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Jianhua WuDepartment of Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Zheyu ShenSchool of Biomedical Engineering, Southern Medical University, Guangzhou, China.
Min ShiDepartment of Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Wangjun LiaoDepartment of Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Zhenzhen WuDepartment of Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Chunlin WangDepartment of Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This corrects the article DOI: 10.3389/fonc.2021.802257.].

Indexed as

biomarkercancer-associated fibroblastsgastric cancerimmune checkpoint blockadePD-1tumor microenvironment

Identifiers

PMID35463347
PMCPMC9022220

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.